PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
ROE: Returns DecliningContracting
Percentile Rank50
3Y CAGR-41.5%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-41.5%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
20251.12%+397.9%
20240.23%+108.2%
2023-2.75%-149.0%
20225.61%-59.7%
202113.94%-